AAAAAA

   
Results: 1-8 |
Results: 8
EFFECT OF CARBOPLATIN ON RESPONSE AND PALLIATION IN HORMONE-REFRACTORY PROSTATE-CANCER
Authors: JUNGI WF BERNHARD J HURNY C SCHMITZ SFH HANSELMANN S GUSSET H PESTALOZZI D GOLDHIRSCH A
Citation: Wf. Jungi et al., EFFECT OF CARBOPLATIN ON RESPONSE AND PALLIATION IN HORMONE-REFRACTORY PROSTATE-CANCER, Supportive care in cancer, 6(5), 1998, pp. 462-468
REDUCED DOSE OF SUBCUTANEOUS CLADRIBINE INDUCES IDENTICAL RESPONSE RATES BUT DECREASED TOXICITY IN PRETREATED CHRONIC LYMPHOCYTIC-LEUKEMIA
Authors: BETTICHER DC RATSCHILLER D SCHMITZ SFH VONROHR A HESS U ZULIAN G WERNLI M TICHELLI A TOBLER A FEY MF CERNY T
Citation: Dc. Betticher et al., REDUCED DOSE OF SUBCUTANEOUS CLADRIBINE INDUCES IDENTICAL RESPONSE RATES BUT DECREASED TOXICITY IN PRETREATED CHRONIC LYMPHOCYTIC-LEUKEMIA, Annals of oncology, 9(7), 1998, pp. 721-726
FEWER INFECTIONS, BUT MAINTAINED ANTITUMOR-ACTIVITY WITH LOWER-DOSE VERSUS STANDARD-DOSE CLADRIBINE IN PRETREATED LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: BETTICHER DC VONROHR A RATSCHILLER D SCHMITZ SFH EGGER T SONDEREGGER T HERRMANN R KRONER T ZULIAN GB CAVALLI F FEY MF CERNY T
Citation: Dc. Betticher et al., FEWER INFECTIONS, BUT MAINTAINED ANTITUMOR-ACTIVITY WITH LOWER-DOSE VERSUS STANDARD-DOSE CLADRIBINE IN PRETREATED LOW-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(3), 1998, pp. 850-858
IDENTIFYING THE TYPES OF MISSINGNESS IN QUALITY-OF-LIFE DATA FROM CLINICAL-TRIALS
Authors: CURRAN D BACCHI M SCHMITZ SFH MOLENBERGHS G SYLVESTER RJ
Citation: D. Curran et al., IDENTIFYING THE TYPES OF MISSINGNESS IN QUALITY-OF-LIFE DATA FROM CLINICAL-TRIALS, Statistics in medicine, 17(5-7), 1998, pp. 739-756
ASSOCIATION BETWEEN BLOOD-TRANSFUSION AND SURVIVAL IN A RANDOMIZED MULTICENTER TRIAL OF PERIOPERATIVE ADJUVANT PORTAL CHEMOTHERAPY IN PATIENTS WITH COLORECTAL-CANCER
Authors: LAFFER U HARDER F JAGGI P METZGER U AEBERHARD P EGELI R ARMA S BARRAS JP LAMPERT VD MARTINOLI S MULLER W SCHRODER R VONHUBEN R WEBER W CASTIGLIONE M GOLDHIRSCH A MAIBACH R SCHMITZ SFH GLOOR F STAMM B WALTZER U
Citation: U. Laffer et al., ASSOCIATION BETWEEN BLOOD-TRANSFUSION AND SURVIVAL IN A RANDOMIZED MULTICENTER TRIAL OF PERIOPERATIVE ADJUVANT PORTAL CHEMOTHERAPY IN PATIENTS WITH COLORECTAL-CANCER, The European journal of surgery, 163(9), 1997, pp. 693-701
CLADRIBINE (2-CDA) GIVEN AS SUBCUTANEOUS BOLUS INJECTIONS IS ACTIVE IN PRETREATED WALDENSTROMS MACROGLOBULINEMIA
Authors: BETTICHER DC SCHMITZ SFH RATSCHILLER D VONROHR A EGGER T PUGIN P STALDER M HESS U FEY MF CERNY T
Citation: Dc. Betticher et al., CLADRIBINE (2-CDA) GIVEN AS SUBCUTANEOUS BOLUS INJECTIONS IS ACTIVE IN PRETREATED WALDENSTROMS MACROGLOBULINEMIA, British Journal of Haematology, 99(2), 1997, pp. 358-363
2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH FOLLICULAR STAGE III-IV NON-HODGKINS-LYMPHOMA
Authors: BETTICHER DC ZUCCA E VONROHR A EGGER T RADFORD JA AMBROSETTI A BURKI K RUFENER B SCHMITZ SFH CERNY T
Citation: Dc. Betticher et al., 2-CHLORODEOXYADENOSINE (2-CDA) THERAPY IN PREVIOUSLY UNTREATED PATIENTS WITH FOLLICULAR STAGE III-IV NON-HODGKINS-LYMPHOMA, Annals of oncology, 7(8), 1996, pp. 793-799
DETERMINING THE MINIMUM SAMPLE-SIZE REQUIRED TO OBTAIN SUFFICIENT PROGENY WITH A DESIRED GENOTYPE AT 2 QUANTITATIVE TRAIT LOCI
Authors: SCHMITZ SFH SCHWAGER SJ POLLAK EJ
Citation: Sfh. Schmitz et al., DETERMINING THE MINIMUM SAMPLE-SIZE REQUIRED TO OBTAIN SUFFICIENT PROGENY WITH A DESIRED GENOTYPE AT 2 QUANTITATIVE TRAIT LOCI, Theoretical and Applied Genetics, 87(1-2), 1993, pp. 136-144
Risultati: 1-8 |